Journal of Andrology, Vol. 26, No. 3, May/June 2005
Copyright © American Society of Andrology
DOI: 10.2164/jandrol.04100
Bioactivity of Androgens Within the Testes and Serum of Normal Men
JONATHAN P. JAROW*,
,
WILLIAM W. WRIGHT
,
TERRY R. BROWN
,
XIAOHUA YAN*,
AND
BARRY R. ZIRKIN
From the * Department of Urology, Johns Hopkins
University School of Medicine, Baltimore, Maryland; and the
Division of Reproductive Biology, Department
of Biochemistry and Molecular Biology, Johns Hopkins University, Bloomberg
School of Public Health, Baltimore, Maryland.
|
Correspondence to: Dr Jonathan P. Jarow, Department of Clinical Chemistry,
University of Helsinki, 601 North Caroline St, Baltimore, MD 21287 (e-mail:
jjarow{at}jhmi.edu). |
Little is known about how human spermatogenesis is regulated, so it is not
surprising that there have been few breakthroughs in the treatment of male
infertility resulting from abnormalities of spermatogenesis. Testosterone is
the predominant intratesticular steroid in both the rat and man. Previous
studies have shown that the testosterone concentration within the rat testis
that is required for the quantitative maintenance of spermatogenesis is far
higher than the total testosterone concentration in rat blood, indicating that
much of the testosterone within the testis might be biologically inactive. In
contrast to the rat, little is known about the androgen requirements for human
spermatogenesis, in part because, until recently, a minimally invasive method
suitable for obtaining intratesticular fluids from the human testis has not
been available. Percutaneous aspiration now makes it feasible to do so. A
major objective of the present study was to assay the bioactive androgen
concentration within the testes of normal, fertile men. Percutaneous
aspiration was used to obtain intratesticular fluid from such men, and we
adapted a highly sensitive recombinant protein mammalian cell-based bioassay
to measure androgen bioactivity. Total intratesticular testosterone
concentration, which we define as immunoreactive testosterone as measured by
radioimmunoassay, was well in excess of that in serum (1236 ± 86 nM vs
11.7 ± 0.7 nM). The concentration of bioactive androgens within the
normal human testis was found to be about two thirds that of the total
testosterone concentration. Interestingly, the concentration of the major,
known binding proteins for testosterone within the testis, serum
hormone-binding globulin (SHBG)/ABP (52.4 ± 9.7 nM), was insufficient
to account for the difference between total testosterone and bioactive
androgens. This indicates that, in addition to its binding to SHBG/ABP,
androgens may also be bound by unknown molecules, and that this contributes to
reducing androgen bioactivity. These observations could have relevance for
understanding the relationship between spermatogenesis and intratesticular
androgens in normal men and in men diagnosed with infertility.
Key words: Intratesticular testosterone, infertility, human
This article has been cited by other articles:

|
 |

|
 |
 
G. Bagchi, J. Wu, J. French, J. Kim, N. H. Moniri, and Y. Daaka
Androgens Transduce the G{alpha}s-Mediated Activation of Protein Kinase A in Prostate Cells
Cancer Res.,
May 1, 2008;
68(9):
3225 - 3231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Boger-Megiddo, N. S. Weiss, M. J. Barnett, G. E. Goodman, and C. Chen
V89L Polymorphism of the 5{alpha}-Reductase Type II Gene (SRD5A2), Endogenous Sex Hormones, and Prostate Cancer Risk
Cancer Epidemiol. Biomarkers Prev.,
February 1, 2008;
17(2):
286 - 291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. JAROW and B. R. ZIRKIN
The Androgen Microenvironment of the Human Testis and Hormonal Control of Spermatogenesis
Ann. N.Y. Acad. Sci.,
December 1, 2005;
1061(1):
208 - 220.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by The American Society of Andrology.